Indexes of transforming growth factors in female patients with human papillomavirus and fertility problems
- Authors: Nevezhkina T.A.1, Markelova E.V.1, Matyshkina L.S.1, Knysh S.V.1, Polyakova K.A.1, Smolyakov I.N.1
-
Affiliations:
- Pacific State Medical University, Vladivostok, Russian Federation
- Section: SHORT COMMUNICATIONS
- Submitted: 17.01.2025
- Accepted: 24.07.2025
- URL: https://rusimmun.ru/jour/article/view/17085
- DOI: https://doi.org/10.46235/1028-7221-17085-IOT
- ID: 17085
Cite item
Full Text
Abstract
The human papillomavirus (HPV) causes one of the most common sexually transmitted viral infections. HPV is the inducing factor of changes in multilayer, flat and metaplastic epithelium, which further leads to cervical intraepithelial neoplasia, with possible carcinogenesis of the cervix. The state of local and general immunity is a crucial factor in emergence of viral infections, including PVI. The immune response may prevent both manifesting and latent HPV infection. Cellular immunity provides a blocking effect on the persistence of the virus and, in some cases, promotes spontaneous regression of lesions. Involvement of cellular immunity in this pathological process is proven by detection of a large number of CD4+ and CD8+ lymphocytes in the infiltrate of regressing condiloma lesions. In general, a decrease in cellular immunity is associated with HPV infection. One of the main roles in regulation of immune response in papillomavirus infection (PVI) is assigned to soluble factors of intermolecular interaction, including transforming growth factors. The aim of our study was to assess the levels of TFR β1, TFR β2, TFR α in women with papillomavirus infection (PVI) and reproductive disorders. Materials and methods: Blood serum samples were studied in 75 female patients, aged 25 to 44 years. The patients were divided into 3 main groups: I, STIs with PVI; II, STIs without PVI, and III, control group. The 1st and 2nd main groups were divided into subgroups depending on reproductive disorders: 1 subgroup was without fertility disorders, and 2 subgroup, infertility. Biological material was collected after the women were examined and diagnosed. The prevailing hyperproduction of transforming growth factors β 1 and 2 in women with papillomavirus infection suggests immunosuppression in this category of patients. This condition may lead to impaired reproductive function due to physiological immunosuppression upon the onset of pregnancy, or due to persistence of the viral process, inducing disturbances in both local and systemic immune responses, thus threatening the normal functions of endometrial tissue, in particular, preventing tight attachment of the fetal egg to the villi of the endometrium and prolongation of pregnancy.
About the authors
T. A. Nevezhkina
Pacific State Medical University, Vladivostok, Russian Federation
Email: www.tanya.ru9292@mail.ru
Assistant Professor, Department of Normal and Pathological Physiology
Russian Federation, 2, Ostryakov Avenue, VladivostokE. V. Markelova
Pacific State Medical University, Vladivostok, Russian Federation
Email: tanya.ru9292@mail.ru
PhD, MD (Medicine), Professor, Head, Department of Normal and Pathological Physiology
Russian Federation, 2 Ostryakov Ave Vladivostok 690002L. S. Matyshkina
Pacific State Medical University, Vladivostok, Russian Federation
Email: tanya.ru9292@mail.ru
PhD (Medicine), Associate Professor, Head, Department of Obstetrics and Gynecology
Russian Federation, 2 Ostryakov Ave Vladivostok 690002S. V. Knysh
Pacific State Medical University, Vladivostok, Russian Federation
Email: s.knysh@m.tgmu.ru
PhD (Medicine), Associate Professor, Department of Normal and Pathological Physiology, Pacific State Medical University
Russian Federation, VladivostokK. A. Polyakova
Pacific State Medical University, Vladivostok, Russian Federation
Author for correspondence.
Email: enderprog@mail.ru
student of the Faculty of Medicine
Russian FederationI. N. Smolyakov
Pacific State Medical University, Vladivostok, Russian Federation
Email: enderprog@mail.ru
student of the Faculty of Medicine
Russian FederationReferences
- Chepurnova N.S., Markelova E.V., Teterlev K.V. Investigation of IL-1 beta, IL-22 and TGF BETA 1 levels in men with chronic urethritis // Pacific Medical Journal. 2016. No.4. pp. 120-121.
- Khryanin AA, Tapil’skaya NI, Knorring GYu. Modern concepts of human papillomavirus infection: epidemiology and treatment tactics of patients with ano-genital warts. Russian Journal of Clinical Dermatology and Venereology. 2020;19(5):719 728. (In Russ.) https://doi.org/10.17116/klinderma202019051719
- Nevezhkina T.A., Markelova E.V., Knysh S.V., Tulupova M.S., Matyshkina L.S. “Changes in serum levels of pro- and anti-inflammatory cytokines in women with papillomavirus infection before and after therapy”, Russian Journal of Immunology/Rossiyskiy Immunologicheskiy Zhurnal, 2024, Vol. 27, no. 1, pp. 109-118. doi: 10.46235/1028-7221-1127-CIS
- Nevezhkina T.A., Tulupova M.S., Kosciusko A.V., Matyushkina L.S. Determination of the level of TFR-α, TFR-β1 and TFR-β2 in anogenital warts// Russian Journal of Allergology. 2017. vol.14. 31. pp.111-112.
- Rischuk S.V., Zagarskikh E.Yu., Gritsenko V.A., Fedorets V.N. Ovarian dysfunction in women with inflammatory diseases of the reproductive system. Bulletin of the Orenburg Scientific Center of the Ural Branch of the Russian Academy of Sciences. 2023. 1: 32 p. [Electronic resource] (URL: http:// elmag.uran.ru:9673/magazine/Numbers/2023-1/Articles/SVR-2023-1.pdf) doi: 10.24411/2304- 9081-2023-11005.
- Rudoy A.S., Moskalev A.V., Sboychakov V.B. The role of transforming growth factor β in the immunopathogenesis of connective tissue diseases// Clinical laboratory diagnostics. 2016. Vol.61. No.2. pp. 103-105.
- Sadretdinov R.A., Voronina L.P., Polunina O.S., Polunin A.A. Levels of markers of collagen metabolism in chronic prostatitis // Kuban scientific medical bulletin. 2016. No.6(161). pp. 109-112.
- Semenova I.V., Novikov D.K., Smirnova O.V., Novikov P.D., Yanchenko V.V. History of immunology in the Republic of Belarus: to the 30th anniversary of the Department of Clinical Immunology and Allergology with the course of FPC and PC of Vitebsk Medical University // Immunopathology, allergology, infectology. 2016. No.2. pp.78-90.
- Sepiashvili R.I. From immunotherapy to personalized targeted immunomodulatory therapy and immunorehabilitation // Allergology and Immunology. 2015. Vol.16. No.4. pp. 323-326.
Supplementary files


